ResMed up on bullish analyst notes after solid quarter
ResMed (ASX:RMD) is still batting eyelashes at brokers, with Ord Minnett reaffirming its @Buy” rating following what it called a @solid” quarterly performance.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headl...
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online